Plugin

Advertisement

Innovent

Innovent and LG Chem sign agreement to treat gout | Jobs Vox

[ad_1] Innovent Biologics and LG Chem Life Sciences have signed an agreement for tigulixostat, a novel non-purine xanthine oxidase inhibitor (XOI) for the chronic treatment of hyperuricemia in patients with gout. Under the terms of the strategic partnership and license agreement, Innovent will receive exclusive rights to develop and commercialize the treatment in China. For … Read moreInnovent and LG Chem sign agreement to treat gout

| Jobs Vox

LG Chem’s ink has partnered with Innovent Biologics for the treatment of gout | Jobs Vox

[ad_1] LG Chem researchers conduct experiments in the company’s laboratories. [LG CHEM] LG Chem has entered into a $95.5 million technology transfer agreement with Nanjing-based Innovent Biologics for gout treatment candidate Tigulixostat. Under the deal, HKEX-listed Innovent Biologics will have exclusive rights to develop and market the gout treatment in China, while LG will retain … Read moreLG Chem’s ink has partnered with Innovent Biologics for the treatment of gout

| Jobs Vox

Innovent and LG Chem announce a strategic collaboration for Tigulixostat, a novel non-purine xanthine oxidase inhibitor for the treatment of gout. | Jobs Vox

[ad_1] ROCKVILLE, Md. and SUZHOU, China, December 15, 2022 /PRNewswire/ — Innovent Biologics (“Innovent”, HKEX: 01801) is a world-class biopharmaceutical company that develops, manufactures and markets high-quality medicines for the treatment of cancer, metabolic, autoimmune, ophthalmic and other major diseases. LG Chem Life Sciences (“LG Chem”), a division of LG Chem, today announced that both … Read moreInnovent and LG Chem announce a strategic collaboration for Tigulixostat, a novel non-purine xanthine oxidase inhibitor for the treatment of gout.

| Jobs Vox

Innovent and LG Chem announce a strategic collaboration for Tigulixostat, a novel non-purine xanthine oxidase inhibitor for the treatment of gout. | Jobs Vox

[ad_1] ROCKVILLE, Md. and SUZHOU, China, December 14, 2022 /PRNewswire/ — Innovent Biologics (“Innovent”, HKEX: 01801) is a world-class biopharmaceutical company that develops, manufactures and markets high-quality medicines for the treatment of cancer, metabolic, autoimmune, ophthalmic and other major diseases. LG Chem Life Sciences (“LG Chem”), a division of LG Chem, today announced that both … Read moreInnovent and LG Chem announce a strategic collaboration for Tigulixostat, a novel non-purine xanthine oxidase inhibitor for the treatment of gout.

| Jobs Vox

Implement tags. Simulate a mobile device using Chrome Dev Tools Device Mode. Scroll page to activate.

x